← Eichor
Condition: Amyloid Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Amyloid

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exercise Training in Transthyretin Cardiac Amyloidosis
NA · 1 location(s) · Brigham and Women's Hospital · NCT05797857
Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
Phase 3 · 1 location(s) · Al-Mustansiriyah University · NCT06882564
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Ch
Phase 1/Phase 2 · 23 location(s) · AbbVie · NCT06158854
Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
Phase N/A · 1 location(s) · Samsung Medical Center · NCT02798705
Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With R
NA · 1 location(s) · Beijing Boren Hospital · NCT06983951
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, an
Phase 2 · 5 location(s) · GlaxoSmithKline · NCT07224672
OCT Angiography and NRAI in Dementia
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT03761381
Exercise in Hereditary ATTR (ATTRv) Amyloidosis
NA · 1 location(s) · University of Maia · NCT07033715
Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid A
NA · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06714097
Registre HEAR, Healthcare European Amyloidosis Registry
Phase N/A · 1 location(s) · Saving Lives Matters · NCT05101304
CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
NA · 1 location(s) · Rigshospitalet, Denmark · NCT07435168
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Phase N/A · 40 location(s) · Alnylam Pharmaceuticals · NCT04561518
Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Phase 4 · 16 location(s) · Alexion Pharmaceuticals, Inc. · NCT07306949
Dominantly Inherited Alzheimer Network (DIAN)
Phase N/A · 26 location(s) · Washington University School of Medicine · NCT00869817
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
Phase N/A · 2 location(s) · Tianjin Medical University · NCT07232459
Comprehensive Program for Hereditary Transthyretin Amyloidosis
Phase N/A · 1 location(s) · Hospital de Alta Complejidad en Red · NCT07213297
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07448779
Prognosis of Cerebral Small Vessel Disease
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05734378
SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT04204642
Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment
NA · 2 location(s) · University Hospital, Geneva · NCT06618872
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · 117 location(s) · SWOG Cancer Research Network · NCT06022939
Echocardiographic Characterization of Cardiac Amyloidosis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05760287
Digital vs. Parent Modeled Toothbrushing
NA · 1 location(s) · University of Southern California · NCT07441148
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidos
Phase 1/Phase 2 · 20 location(s) · Regeneron Pharmaceuticals · NCT06292780
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
Phase 2 · 2 location(s) · Mayo Clinic · NCT05898646
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREK
Phase N/A · 6 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06205953
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms
EARLY_Phase 1 · 1 location(s) · Anhui Provincial Hospital · NCT07085559
The Norwegian Immunotherapy in Multiple Myeloma Study
Phase N/A · 23 location(s) · St. Olavs Hospital · NCT06855121
Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Phase N/A · 1 location(s) · Yale University · NCT07398950
Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06907836
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.